Session P1	Room P (4F)	Systemic Disease and Pulmonary Hypertension
Chairs		Shin-Seok Lee (Chonnam National Univ., Korea) Jo Won Jung (Yonsei Univ., Korea)
July 11 (Fri.) 09:00 - 10:40	09:00-09:20	SP1-1	Obesity and/or Sleep Apnea Jang Ho Lee (Univ. of Ulsan, Korea)
	09:20-09:40	SP1-2	Thyroid Disease Sung-Hee Shin (Inha Univ., Korea)
	09:40-10:00	SP1-3	Liver Disease Jin Young Song (Sungkyunkwan Univ., Korea)
	10:00-10:20	SP1-4	Hemato-Oncology Disease Dae-Hee Kim (Univ. of Ulsan, Korea)
	10:20-10:40	Panel Discussion Ji Seok Bang (Bucheon Sejong Hospital, Korea) Ran Heo (Hanyang Univ., Korea) Jae Hyun Jung (Korea Univ., Korea) Jae Seung Lee (Univ. of Ulsan, Korea)

Session H1	Room H (4F)	Basic Research Session: Can We Find Our Weapon through Deep Phenotyping? Korean
Chairs		강석민 (대한심장학회 이사장) 김원호 (국립보건연구원 만성질환융복합연구부 부장)
July 11 (Fri.) 09:00-10:40	09:00-09:20	SH1-1	Unlocking the Genetic Secrets of Pulmonary Artery Hypertension: Insights from the KANK1 Discovery in the PHOENIKS Cohort 최정민 (고려대 유전학과)
	09:20-09:40	SH1-2	Personalized Disease Modeling of Pulmonary Hypertension Using a Multi-Organ Platform from Patient-derived iPSCs 박진규 (한림의대 생리학과)
	09:40-10:00	SH1-3	single-cell multiomics approach to develop diagnostic tools for the early-phase PAH 진석원 (광주과학기술원(GIST))
	10:00-10:20	SH1-4	PHOENIKS for the longitudinal deep phenotyping platform, Now and Future 이수연 (국립보건연구원 심혈관질환과)
	10:20-10:40	Panel Discussion 박훈준 (가톨릭의대 심장내과) 최효인 (성균관의대 심장내과) 장영우 (가천의대 심장내과)

Session P2	Room P (4F)	Joint Session with the Saudi Association for PH (SAPH) : How to Cooperate in the Research in Asia Pacific Region
Chairs		Wook-Jin Chung (President, KPHS, Korea) Abdullah M. Aldalaan (President, Saudi Association for PH, Saudi Arabia)
July 11 (Fri.) 11:00-12:40	11:00-11:20	SP2-1	PAH; Where Research Leads to Treatment Advances Abdullah M. Aldalaan (President, Saudi Association for PH, Saudi Arabia)
	11:20-11:40	SP2-2	Current Status of PH research in EASOPH region Youngwoo Jang (Gachon Univ., Korea)
	11:40-12:00	SP2-3	Percutaneous Interventional Modalities to Treat PH Alkhodair Abdullah (SAPH Board Member, Saudi Arabia)
	12:00-12:20	SP2-4	How to cooperate on the research of PH in Asia Pacific region Hiromi Matsubara (Okayama Medical Center, Japan)
	12:20-12:40	Panel Discussion Se Yong Jung (Yonsei Univ., Korea) Hun-Jun Park (The Catholic Univ. of Korea, Korea) Ji-Hun Jang (Inha Univ., Korea) Hyo-In Choi (Sungkyunkwan Univ., Korea)

Session H2	Room H (4F)	Best Oral Presentation
Chairs		Dae-Hee Kim (Univ. of Ulsan, Korea) Hyun-Sook Kim (Soonchunhyang Univ., Korea)
July 11 (Fri.) 11:00-12:40	11:00-11:15	SH2-1	Arteriovenous oxygen content difference: a diagnostic predictor for preselecting invasive treatnent in congehital heart disease related pulmonary arterial hypertension Ashfaq Ahmad (First Affiliated Hospital, Xi’an Jiaotong Univ., Pakistan)
	11:15-11:30	SH2-2	Preclinical Models Support the Synergistic Potential of Seralutinib and Sotatercept in Treating Pulmonary Arterial Hypertension Ravikumar Sitapar (Gossamer Bio, Inc, USA)
	11:30-11:45	SH2-3	Epidemiology, Clinical Outcomes, and Economic Evaluation of Pulmonary Hypertension in Southeast Asia Rosinta Hotmaida Pebrianti Purba (The Pranala Institute, Indonesia)
	11:45-12:00	SH2-4	Mitral E Wave Deceleration Slope as A Predictor of Clinical Outcome In Pulmonary Hypertension. Taeil Yang (Gachon univ., Korea)
	12:00-12:15	SH2-5	AI-Driven Early Detection and Risk Stratification in Pulmonary Hypertension: Leveraging Open-Source Multimodal Data Rao Faizan (Kyung Hee Univ., Korea)
	12:15-12:40	Panel Discussion Kyung Eun Ha (Gachon Univ., Korea) Hyun-Jin Kim (Hanyang Univ., Korea) Kee Soo Ha (Korea Univ., Korea) U Ram Jin (Ajou Univ., Korea)

Luncheon Session 1	Room P (4F)	Johnson & Johnson Korean
Chairs		김계훈(전남의대 심장내과) 박정웅(가천의대 호흡기알레르기내과)
July 11 (Fri.) 12:40-13:20	12:40-13:00	L1-1	Advancing PAH Care: Risk Assessment Strategies and Maximizing outcomes Through Selexipag’s MTD 이상현 (양산부산대병원 심장내과)
	13:00-13:20	L1-2	Optimizing PAH care: WSPH Treatment Implications and Early combination Therapy with Selexipag 김경희 (인천세종병원 심장내과)

Luncheon Session 2	Room H (4F)	Bayer Korean
Chairs		홍석근 (부천세종병원) 신익균 (가천대길병원)
July 11 (Fri.) 12:40-13:20	12:40-13:00	L2-1	Clinical Evolution in CTEPH and PAH Management: A Decade of Adempas Experience in Taiwan Yih-Jer Wu (MacKay Memorial Hospital, Taipei, Taiwan)
	13:00-13:20	L2-2	Transforming PAH Patient Care in Korea: Clinical Implications of Adempas Integration into Treatment Algorithms 김대희 (울산의대 심장내과)

Session P3	Room P (4F)	EASOPH Session: Efforts to Cure PH in Each Country
Chairs		Kuo Yang Wang (China Medical Univ. Hospital, Taiwan) Keiko Yamauchi-Takihara (Osaka Univ., Japan) Kye Hun Kim (Chonnam National Univ., Korea)
July 11 (Fri.) 13:30-15:10	13:30-13:50	SP3-1	South Korea Jung Hyun Choi (Pusan National Univ., Korea)
	13:50-14:10	SP3-2	Japan Yoshihiro Fukumoto (Kurume Univ. School of Medicine, Japan)
	14:10-14:30	SP3-3	China Zhi-Cheng Jing (Guangdong Provincial People’s Hospital, China)
	14:30-14:50	SP3-4	Taiwan Chih-Hsin Hsu (National Cheng Kung Univ. Taiwan)
	14:50-15:10	Panel Discussion In-Cheol Kim (Keimyung Univ., Korea) Kyung-Jin Ahn (Gachon Univ., Korea) Ran Heo (Hanyang Univ., Korea)

Session H3	Room H (4F)	Joint Session with Korean Society of Heart Failure (KSHF) Korean
Chairs		박대균 (대한심부전학회 회장) 유병수 (대한심부전학회 이사장)
July 11 (Fri.) 13:30-15:10	13:30-13:50	SH3-1	Significance of Pulmonary Hypertension in Heart Failure? 최진오 (성균관의대 순환기내과)
	13:50-14:10	SH3-2	How to suspect and evaluate PH in HF? 심지영 (연세의대 심장내과)
	14:10-14:30	SH3-3	How to manage PH in Advanced HF? 김민석 (울산의대 심장내과)
	14:30-14:50	SH3-4	Future perspectives in PH in HF and MD-CpcPH trial 양태일 (가천의대 심장내과)
	14:50-15:10	Panel Discussion 오재원 (연세의대 심장내과) 박진주 (분당서울대병원) 양태일 (가천의대 심장내과) 정현주 (명지병원 심장내과)

Session P4	Room P (4F)	Young Investigator Award
Chairs		Yong Bum Park (Hallym Univ., Korea) Gi Beom Kim (Seoul National Univ., Korea)
July 11 (Fri.) 15:30-16:45	15:30-15:45	SP4-1	AI-Assisted Echocardiography for Early Detection of Pulmonary Arterial Hypertension in Primary Care: A Multicenter Prospective Study Dharmendra Kumar Khatri (Nims Jaipur, India)
	15:45-16:00	SP4-2	Real-World Experience with Sotatercept in PAH: Hematologic Effects and Safety Considerations Cze Ci Chan (Linkou Chang Gung Memorial Hospital, Taiwan)
	16:00-16:15	SP4-3	Pulmonary Hypertension with Multifactorial Pathogenesis: A Case Report Dominated by Autoantibodies and Cardiomyopathy-Associated Genes Zizheng Yi (The First Affiliated Hospital, Sun Yat-sen Univ., China)
	16:15-16:30	SP4-4	Evaluation of Echocardiographic Validity for Estimating PVR and Mean PAP Compared to Right Heart Catheterization in Suspected Pulmonary Hypertension KilYoon Pack (Gachon Univ., Korea)
	16:30-16:45	SP4-5	The effect of Udenafil to improve exercise capacity for Fontan patients Duk Woo Lee (Seoul National Univ., Korea)
	10 min presentation +5 min discussion	Panel Discussion Sang Hyun Lee (Pusan National Univ., Korea) Kyung Eun Ha (Gachon Univ., Korea) Jue Seong Lee (Korea Univ., Korea) Hyeonju Jeong (Hanyang Univ., Korea)

Session H4	Room H (4F)	Special Lecture Korean
Chairs		정욱진 (대한폐고혈압학회 회장)
July 11 (Fri.) 15:30-16:00	15:30-16:00	SH4-1	Targeting the inflammatory activity of a tRNA synthetase for the treatment of pulmonary arterial hypertension 김성훈 (자이메디)

Session P5	Room P (4F)	Outlook Session on Changing Pulmonary Hypertension Guidelines
Chairs		Stephan Rosenkranz (Univ. of Cologne, Germany) Hae-Ok Jung (The Catholic Univ. of Korea, Korea)
July 11 (Fri.) 16:45-18:25	16:45-17:05	SP5-1	European perspective Stephan Rosenkranz (Univ. of Cologne, Germany)
	17:05-17:25	SP5-2	US perspective Nick H. Kim (UCSD, USA)
	17:25-17:45	SP5-3	Japanese perspective Hiromi Matsubara (Okayama Medical Center, Japan)
	17:45-18:05	SP5-4	Korean perspective Kyung-Hee Kim (Incheon Sejong Hospital, Korea)
	18:05-18:25	Panel Discussion Hye Won Kwon (Seoul National Univ., Korea) Jae Hyun Jung (Korea Univ., Korea) In-Jeong Cho (Ewha Womans Univ., Korea) Sang Jae Rhee (Wonkwang Univ., Korea)

Session H5	Room H (4F)	정책 세션: Dedicated to cure PH Korean
Chairs		조명찬 (충북의대 심장내과) 박현영 (국립보건연구원 원장)
July 11 (Fri.) 16:45-18:25	16:45-17:05	SH5-1	폐동맥고혈압 환자들이 바라는 것들은.. 윤영진 (폐동맥고혈압환우회 회장)
	17:05-17:25	SH5-2	폐동맥고혈압과 폐고혈압 : 무엇이 다르고 왜 새로운 질환군인가? 김대희 (대한폐고혈압학회 총무이사)
	17:25-17:45	SH5-3	국내 폐동맥고혈압과 폐고혈압 관리의 문제점 정욱진 (대한폐고혈압학회 회장)
	17:45-18:05	SH5-4	건강보험 급여등재 절차에 대한 이해 이숙현 (건강보험심사평가원 신약등재부)
	18:05-18:25	Panel Discussion 이지현 (한국경제신문 바이오헬스부) 이진한 (동아일보 의학전문기자) 허란 (대한폐고혈압학회 홍보이사)

Morning Session 1	Room P (4F)	Johnson & Johnson Korean
Chairs		최재영 (연세의대 소아심장과) 한승환 (가천의대 심장내과)
July 12 (Sat.) 08:30-09:00	08:30-08:45	M1-1	Optimal approaches for early screening of PAH in Connective Tissue Diseases (CTD-PAH) 허란 (한양의대 심장내과)
	08:45-09:00	M1-2	Real-World Clinical Experience with Macitentan and Selexipag in CHD-PAH 정세용 (연세의대 소아심장과)

Morning Session 2	Room H (4F)	Samjin Pharm. Korean
Chairs		강웅철 (가천의대 심장내과) 성기철 (성균관의대 심장내과)
July 12 (Sat.) 08:30-09:00	08:30-09:00	M2-1	PH due to LHD and CpcPH: Differential Diagnosis and Individualized Treatment Strategies 김인철 (계명의대 심장내과)

Session P6	Room P (4F)	Joint Session with the Korean Adult Congenital Heart Disease Society
Chairs		June Huh (Sungkyunkwan Univ., Korea) Goo-Yeong Cho (Seoul National Univ., Korea) Sukkeun Hong (Bucheon Sejong Hospital, Korea)
July 12 (Sat.) 09:00-10:40	09:00-09:20	SP6-1	Pathophysiology and diagnosis of Eisenmenger syndrome Sang Hyun Lee (Pusan National Univ., Korea)
	09:20-09:40	SP6-2	Selective pulmonary vasodilator for Eisenmenger syndrome Gi Beom Kim (Seoul National Univ., Korea)
	09:40-10:00	SP6-3	Treat and repair strategy for adult CHD with PAH Jung Yoon Kim (Sejong General Hospital, Korea)
	10:00-10:20	SP6-4	Pregnancy and delivery in female with Eisenmenger syndrome Kyung-Jin Ahn (Gachon Univ., Korea)
	10:20-10:40	Panel Discussion Seungmin Baek (Seoul National Univ., Korea) Hyo-Suk Ahn (The Catholic Univ. of Korea, Korea) Eung Re Kim (Bucheon Sejong Hospital, Korea)

Session H6	Room H (4F)	Issues for pulmonary hypertension associated with rheumatic disease Korean
Chairs		이신석 (전남의대 류마티스내과) 이은봉 (서울의대 류마티스내과)
July 12 (Sat.) 09:00-10:40	09:00-09:20	SH6-1	The hidden threat: understanding epidemiology and pathogenesis of rheumatic disease (systemic sclerosis) associated PH 윤지열 (연세의대 류마티스내과)
	09:20-09:40	SH6-2	Advance in screening and risk stratification in rheumatic disease-associated PH 정재현 (고려의대 류마티스내과)
	09:40-10:00	SH6-3	Updates in management strategies for rheumatic diasease-associated PH 김현숙 (순천향의대 류마티스내과)
	10:00-10:20	SH6-4	Case-Based discussion: Solving real-world challenges in rheuamtic disease associated PH 여지나 (가천의대 류마티스내과)
	10:20-10:40	Panel Discussion 전찬홍 (순천향의대 류마티스내과) 정중화 (조선의대 순환기내과) 최효인 (성균관의대 심장내과) 김형윤 (인천세종병원 심장내과)

Session P7	Room P (4F)	New Weapons on PH Battle Field
Chairs		Stephan Rosenkranz (Univ. of Cologne, Germany) Hiromi Matsubara (NHO Okayama Medical Center, Japan)
July 12 (Sat.) 10:50-12:10	10:50-11:05	SP7-1	Activin Signaling Inhibitor, sotartercept Jenny Yang (UCSD, USA)
	11:05-11:20	SP7-2	Pulmonary Artery Denervation (PADN): an innovative Pulmonary Hypertension Therapy Hang Zhang (Nanjing Medical Univ., China)
	11:20-11:35	SP7-3	Tyrosine Kinase Inhibitor, seralutinib Stephan Rosenkranz (Univ. of Cologne, Germany)
	11:35-11:50	SP7-4	Soluble Gualylate Cyclase Activator,mosliguat Ubaldo Martin (Pulmovant, USA)
	11:50-12:10	Panel Discussion Ju-Hee Lee (Chungbuk National Univ., Korea) Jae-Hyeong Park (Chungnam National Univ., Korea) Jin Young Song (Sungkyunkwan Univ., Korea) Hoon Ko (Pusan National Univ., Korea)

Session H7	Room H (4F)	All about ILD-PH, COPD-PH and CTEPH Korean
Chairs		김호중 (성균관의대 호흡기내과) 장항제 (인제의대 호흡기내과)
July 12 (Sat.) 10:50-12:10	10:50-11:10	SH7-1	Inhaled treprostinil in PH-ILD: new milestone therapy and future 김호철 (울산의대 호흡기내과)
	11:10-11:30	SH7-2	Vascular phenotype in heterogeneous COPD 신선혜 (성균관의대 호흡기내과)
	11:30-11:50	SH7-3	CTEPH Nick H. Kim (UCSD, USA)
	11:50-12:10	Panel Discussion 김우현 (한양의대 심장내과) 이재승 (울산의대 호흡기내과) 황석재 (검단탑병원 순환기내과)

Session PH8	Room P (4F)	Presidential Lecture and Plenary Lectures
Chairs		Kuo Yang Wang (China Medical Univ. Hospital, Taiwan) Keiko Yamauchi-Takihara (Osaka Univ., Japan) Abdullah M. Aldalaan (President, Saudi Association for PH, Saudi Arabia)
July 12 (Sat.) 12:10-13:10	12:10-12:30	PH8-1	How to overcome PH? - Proposal of OPUS-K Wook-Jin Chung (President, KPHS, Gachon Univ. Gil Medical Center, Korea)
	12:30-12:50	PH8-2	Ethnic Difference in PAH Zhi-Cheng Jing (Guangdong Provincial People’s Hospital, China)
	12:50-13:10	PH8-3	What's new in upcoming global PH guidelines? Stephan Rosenkranz (Univ. of Cologne, Germany)

Luncheon Session 3	Room P (4F)	Samjin Pharm. Korean
Chairs		Namsik Chung (PHILMEDIS CLINICS, Korea) Yong Bum Park (Hallym Univ., Korea)
July 12 (Sat.) 13:10-13:50	13:10-13:30	L3-1	Optimal treatment of PAH patients in KOREA 박재형 (충남의대 심장내과)
	13:30-13:50	L3-2	Practical Approach to PAH Management: Real-world Experience with Maciten™ 김경희 (인천세종병원 심장내과)

Luncheon Session 4	Room H (4F)	Chong Kun Dang & Celltrion Pharm. Korean
Chairs		백효채 (명지병원 흉부외과) 최의영 (강남세브란스병원 심장내과)
July 12 (Sat.) 13:10-13:50	13:10-13:30	L4-1	Beta-blocker therapy in patients with AMI : Not the same 박훈준 (가톨릭의대 심장내과)
	13:30-13:50	L4-2	Intensive Treatment Strategy in Hypertension 정혜문 (경희의대 심장내과)

Session P9	Room P (4F)	Case Competition Session
Chairs		Hyoung Doo Lee (Pusan National Univ., Korea) Kye Hun Kim (Chonnam National Univ., Korea)
July 12 (Sat.) 14:10-15:25	14:10-14:25	SP9-1	Transcatheter Stenting of a Tiny Patent Ductus Arteriosus for Right Heart Decompression in Advanced Pulmonary Arterial Hypertension Phuc Nang Vu (Tam Anh general hospital of Hochiminh city, Viet Nam)
	14:25-14:40	SP9-2	Congenital Portosystemic Shunt Treated By Interventional Device Closure : A Case Report Dongjin Lim (Seoul National Univ. Children's Hospital, Korea)
	14:40-14:55	SP9-3	Pulmonary endarterectomy in a patient with chronic thromboembolic pulmonary hypertension and antiphospholipid syndrome Thuy Thuc Minh Pham (Tam Anh general hospital of Hochiminh city, Viet Nam)
	14:55-15:10	SP9-4	Coexistence of Pulmonary Arterial Hypertension and Hepatopulmonary Syndrome in a Young Adult with Congenital Heart Disease: A Case Report Kyungeun Ha (Gachon Univ., Korea)
	10 min presentation +5 min discussion	Panel Discussion Sun Hwa Lee (Jeonbuk National Univ., Korea) Jae Hyun Jung (Korea Univ., Korea) So Ick Jang (Bucheon Sejong Hospital, Korea) Ala Woo (Yonsei Univ., Korea)

Session H9	Room H (4F)	개원의 및 전공의 교육 I Korean
Chairs		박용범 (한림의대 호흡기내과) 장혁재 (연세의대 심장내과)
July 12 (Sat.) 14:10-15:50	14:10-14:30	SH9-1	폐고혈압의 정의 및 분류 정세용 (연세의대 소아심장과)
	14:30-14:50	SH9-2	폐고혈압의 진단 및 유전 검사 김경희 (인천세종병원 심장내과)
	14:50-15:10	SH9-3	폐고혈압에서 우심도자검사의 분석 김정윤 (부천세종병원 소아심장과)
	15:10-15:30	SH9-4	폐고혈압의 약물적 치료 이재승 (울산의대 호흡기내과)
	15:30-15:50	Panel Discussion 곽서연 (고려의대 심장내과) 윤민재 (서울의대 심장내과) 정유정 (가천의대 중환자의학과)

Session P10	Room P (4F)	It’s ‘Right’ Time to Launch ‘Right Heart Journal’
Chairs		Wook-Jin Chung (E-i-C, RHJ, Korea) Nick H. Kim (UCSD, USA) Shigetoyo Kogaki (Osaka General Medical Center, Japan)
July 12 (Sat.) 15:40-17:20	15:40-16:00	SP10-1	Why we need 'RHJ'? From EASOPH's perspectives Chih-Hsin Hsu (National Cheng Kung Univ., Taiwan)
	16:00-16:20	SP10-2	Why we need 'RHJ'? From Global perspectives Nick H. Kim (UCSD, USA)
	16:20-16:40	SP10-3	How do we develop 'RHJ' to the top soon? From EASOPH's perspectives Yoshihiro Fukumoto (Kurume Univ. School of Medicine, Japan)
	16:40-17:00	SP10-4	How do we develop 'RHJ' to the top soon? From Global perspectives Stephan Rosenkranz (Univ. of Cologne, Germany)
	17:00-17:20	Panel Discussion Jin Oh Na (Korea Univ., Korea) Hiromi Matsubara (Okayama Medical Center, Japan) Chan Hong Jeon (Soonchunhyang Univ., Korea) Yih-Jer Wu (MacKay Memorial Hospital, Taipei, Taiwan)

Session H10	Room H (4F)	개원의 및 전공의 교육 II Korean
Chairs		김형섭 (계명의대 심장내과) 유승기 (이화의대 건진의학과)
July 12 (Sat.) 15:50-17:20	15:50-16:10	SH10-1	간질환으로 인한 문맥폐고혈압의 진단 및 치료 김대희 (울산의대 심장내과)
	16:10-16:30	SH10-2	만성 폐질환으로 인한 폐고혈압의 진단 및 치료 장항제 (인제의대 호흡기내과)
	16:30-16:50	SH10-3	만성 폐색전증으로 인한 폐고혈압 (CTEPH)의 진단 및 치료 하경은 (가천의대 심장내과)
	16:50-17:10	SH10-4	선천성 심질환과 관련된 폐고혈압의 진단 및 치료 장소익 (부천세종병원 소아심장과)
	17:10-17:20	Panel Discussion 정혜문 (경희의대 심장내과) 현준호 (울산의대 심장내과) 안경진 (가천의대 소아심장과) 위진 (가천의대 심장내과)